Innovative Research Award
Ahmed Altuwiajri — King Saud University, Saudi Arabia
Ahmed Altuwiajri is a researcher affiliated with King Saud University in Saudi Arabia whose stated subject area is pharmacology. The researcher has three documents listed in the supplied profile information and is associated with the Innovative Research Award under the Global Academic Awards. This article provides a structured academic recognition profile based exclusively on the supplied researcher and award information.
Abstract
This academic recognition profile presents Ahmed Altuwiajri of King Saud University, Saudi Arabia, in connection with the Innovative Research Award at the Global Academic Awards. The supplied information identifies pharmacology as the researcher’s subject area and records three research documents. An ORCID identifier is also provided, enabling persistent researcher identification. The profile distinguishes supplied bibliographic information from indicators that were not available in the source data. [1]
Keywords
- Ahmed Altuwiajri
- Innovative Research Award
- Pharmacology
- King Saud University
- Saudi Arabia
- Global Academic Awards
- Academic Research
- Research Innovation
Introduction
Pharmacology is the scientific discipline concerned with the study of drugs, their biological effects, mechanisms of action, therapeutic applications, and interactions with biological systems. Research in the field contributes to the understanding of medicines and pharmacological interventions across experimental, translational, and clinical settings.
Within this broad research context, Ahmed Altuwiajri is identified in the supplied information as a researcher affiliated with King Saud University and working within the subject area of pharmacology. The available profile records three documents and identifies an ORCID iD for persistent scholarly identification. [1]
Research Profile
The supplied research profile associates Ahmed Altuwiajri with King Saud University in Saudi Arabia and identifies pharmacology as the principal subject area. The documented research output consists of three documents. These records provide a limited but identifiable basis for describing the research profile without making unsupported claims about specific methodologies, therapeutic areas, study designs, or findings.
The researcher’s ORCID iD is 0009-0006-8129-4507. ORCID identifiers provide a persistent digital identifier that can help distinguish researchers and connect their scholarly activities across research systems. [2]
The supplied information does not include a Scopus Author ID, citation count, or h-index. Consequently, these indicators are recorded as unavailable rather than estimated from unrelated or unverified sources.
Research Contributions
Based on the supplied data, the principal documented contribution of the profile is its representation of research activity within pharmacology at King Saud University. Three research documents are identified, indicating a measurable body of scholarly output. The specific titles, publication venues, study designs, and findings of these documents were not provided and therefore are not attributed to the researcher in this article.
- Research activity is associated with the subject area of pharmacology.
- The supplied profile records three research documents.
- The researcher is affiliated with King Saud University.
- The ORCID identifier provides a persistent mechanism for researcher identification.
- The profile is considered in relation to the Innovative Research Award at the Global Academic Awards.
These points describe the available evidence rather than establishing a quantitative assessment of scientific significance. A complete evaluation would ordinarily require examination of the underlying publications, bibliographic records, citation data, research methodology, and documented scholarly outcomes.
Publications
The supplied profile specifies a total of 3 documents. Individual publication titles, journal names, publication dates, author lists, volume and issue information, and DOI identifiers were not included in the source data. Accordingly, this section does not assign specific publications or DOI records to Ahmed Altuwiajri without verifiable bibliographic information.
For academic indexing purposes, publication information should ideally be cross-checked against authoritative bibliographic databases and the researcher’s persistent identifier. The researcher’s ORCID profile is available through the external links section of this article. [2]
No DOI citation can be responsibly included for an individual publication because no publication-specific DOI was supplied. This avoids associating an unrelated DOI with the researcher’s work.
Research Impact
Research impact can be assessed through multiple dimensions, including scholarly publications, citations, collaboration, methodological contributions, translation into practice, and broader scientific or societal relevance. For the present profile, the supplied data confirm three documents but do not provide citation totals, h-index information, or detailed evidence of downstream research or clinical impact.
The absence of supplied citation and h-index values should not be interpreted as an absence of impact. Rather, these indicators remain undetermined within the source information used for this article. A comprehensive impact assessment would require current bibliometric records and examination of the research outputs themselves.
Award Suitability
The supplied information connects Ahmed Altuwiajri with the Innovative Research Award presented under the Global Academic Awards. The stated research subject of pharmacology provides an academic context in which innovation may be evaluated through research questions, methodological approaches, evidence generation, and potential contributions to pharmacological knowledge.
Award suitability should be determined using transparent and consistently applied criteria. Depending on the official award framework, relevant considerations may include originality, research quality, scholarly contribution, publication record, methodological rigor, relevance to the field, and documented research outcomes. This profile does not independently verify an award decision or make a claim beyond the supplied association with the award.
- Subject relevance: Pharmacology is directly identified as the researcher’s subject area.
- Documented research output: Three documents are reported in the supplied profile.
- Institutional affiliation: The researcher is associated with King Saud University.
- Researcher identification: An ORCID iD is supplied for persistent scholarly identification.
- Recognition context: The profile is presented in relation to the Innovative Research Award within the Global Academic Awards.
Conclusion
Ahmed Altuwiajri is identified as a pharmacology researcher affiliated with King Saud University in Saudi Arabia. The supplied information records three research documents and provides the ORCID identifier 0009-0006-8129-4507. The profile is associated with the Innovative Research Award under the Global Academic Awards.
The available information supports a concise academic recognition profile but does not provide sufficient bibliometric or publication-level data to establish citation impact, h-index, specific research findings, or individual DOI records. Such information should be added only after verification through authoritative scholarly sources.
External Links
References
- ORCID. (n.d.). Ahmed Altuwiajri — ORCID iD 0009-0006-8129-4507. ORCID.
https://orcid.org/0009-0006-8129-4507
- TPC2 regulates proteomic remodeling, bioenergetic phenotypes, and mitochondrial stress adaptation in melanoma. https://link.springer.com/article/10.1007/s44446-026-00088-w7
- Global Academic Awards. (n.d.). Global Academic Awards.
https://globalacademicawards.com/
- Isoproterenol Induces Cardiac Injury and Senescence in Sprague–Dawley Rats: A Cost-Effective Pharmacological Mode. lhttps://doi.org/10.3390/biomedicines14071445